Improvement of Care & Outcome

An important goal for Diabeter is to optimize the outcome for every patient, and minimize the burden of the disease. Our use of an electronic disease management system (VCare) for over 15 years means that we have collected a vast amount of data, as well as experience. Rigorous scientific analyses of our datasets makes it possible for us to identify factors associated with better outcomes, and improve the care that we deliver.


Diabeter is also actively involved in clinical trials and other research, contributing to the continual improvement in diabetes care that has occurred in recent years: these include advances in continuous glucose measurement, new insulin delivery systems and other devices, and new therapeutic options such as very short-acting or very long-acting insulins.


As these new medicines and new technologies enter the real world, we can make use of the VCare system to continually evaluate their impact on the management of T1DM. We can provide useful data on usability, efficacy, safety, and cost-effectiveness.


Our work in the field of outcomes research has included:

  • Identifying factors associated with the successful use of insulin pumps and continuous glucose sensors
  • Investigating the use, impact, and outcome of new forms of treatment and patient-doctor communication, such as our ‘Ther@piemail’
  • Analyzing data for screening and treatment of concomitant diseases such as hypothyroidism and celiac disease
  • Testing new insulin analogues such as insulin degludec (Tresiba)
  • Testing co-medications such as GLP-1 analogues


Through research such as this, we can help refine and optimize treatment and its outcomes, developing the most appropriate personalized care for each patient.

Introduction Projects Researchers Collaborators Publications Funders

Friends of Diabeter

Diabeter Rotterdam
Blaak 6
3011 TA Rotterdam
Telephone: 088-280 7277
Fax: 088-280 9299
© 2016 Diabeter | Terms of Use | Privacy Statement